Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New three-year Exclusive Agreement with Nouryon

8 Oct 2019 07:00

RNS Number : 0544P
Quadrise Fuels International PLC
08 October 2019
 

Quadrise Fuels International plc

("QFI", "Quadrise" or the "Company")

New three-year Exclusive Agreement with Nouryon

Quadrise Fuels International plc (AIM: QFI) is pleased to announce it has entered into an Exclusive Global Collaboration and Emulsifiers Sales Agreement ("Agreement") with Nouryon for the exclusive global collaboration and supply of goods and services for future MSAR® projects. The Agreement will run for three years to October 2022.

This Agreement replaces the two separate contracts with AkzoNobel that were previously extended to November 2019 (as announced by the Company on 26 November 2018), having been originally entered into in November 2013. Prior to this, Quadrise had been party to an Alliance Agreement with AkzoNobel from November 2004.

Commenting on this development:

Mike Kirk, Executive Chairman of QFI, said:

"We are delighted that we have been able to revert to a new, three-year agreement with Nouryon, after putting in place the shorter-term agreement in November 2018, as a temporary measure whilst the relevant Nouryon entities were formed. The new contract with our core technology partner, Nouryon, reinforces the commitment of both parties to commercialising the global MSAR® business. Our long-term relationship with Nouryon continues to underpin our ability to move the Company towards long-term commercial revenues, as we progress our business development activities towards large-scale trials followed by commercial roll-out. This new contract enables Quadrise to both progress and protect the IP inherent to MSAR® and to provide the exclusive supply to Quadrise of the chemicals for the production of MSAR®."

Dr Staffan Asplund, R&D Director, Nouryon, said:

"We have been working with Quadrise for many years and we are pleased to be able to continue supporting their progression, through this new contract. It is a great example of how Nouryon is able to deliver a unique, customised surfactant system, that underpins Quadrise's proprietary MSAR® fuel technology that delivers significant benefits for existing producers and users of heavy fuel oil."

Background to the Nouryon Agreement:

The Agreement between Quadrise International Limited ("QIL"), a subsidiary of the Company, and Nouryon Surface Chemistry AB ("NSC") continues the commercial relationship between the parties relating to the purchase and supply of goods and associated technical services to MSAR® projects in development. QIL purchases, and will continue to purchase, speciality chemicals used as emulsifiers exclusively from NSC, which NSC supply exclusively to QIL for oil-in-water emulsion fuel applications.

Intellectual Property arising from any future joint development activity, or relating to past work such as MSAR® Marine fuels development, is jointly owned between the parties. The Agreement is exclusive in the field of oil-in-water emulsion fuels research and development.

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

Quadrise Fuels International Plc

Mike Kirk, Executive Chairman

+44 (0)20 7031 7321

Jason Miles, Chief Operating Officer

Nominated Adviser

Cenkos Securities plc

Dr Azhic Basirov

+44 (0)20 7397 8900

Ben Jeynes

Katy Birkin

Joint Broker

Peel Hunt LLP

Richard Crichton

+44 (0)20 7418 8900

David McKeown 

Joint Broker

Shore Capital Stockbrokers Limited

Toby Gibbs

Fiona Conroy

 

+44 (0)20 7408 4090

Public & Investor Relations

FTI Consulting

Ben Brewerton

+44 (0)20 3727 1000

Ntobeko Chidavaenzi

 

 

For further information on Nouryon, please refer to their website at www.nouryon.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRUGGQCUUPBGQM
Date   Source Headline
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
6th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20218:00 amEQSEdison Investment Research Limited: Quadrise Fuels International (QFI): Cleaner fuel, cleaner planet
26th Nov 20213:30 pmRNSResult of AGM
26th Nov 20217:00 amRNSAGM Statement
1st Nov 20215:00 pmRNSPosting of Annual Report and Notice of AGM
20th Oct 20215:45 pmRNSMorocco Travel Restrictions
5th Oct 20214:41 pmRNSSecond Price Monitoring Extn
5th Oct 20214:35 pmRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSFinal Results, Directorate Change & Notice of AGM
1st Oct 20217:00 amRNSTotal Voting Rights
24th Sep 20217:00 amRNSNotice of Results and Investor Presentation
23rd Sep 20217:00 amRNSUtah Project Update
20th Sep 20214:36 pmRNSPrice Monitoring Extension
3rd Sep 20212:30 pmRNSIssue of Share Options & Director/PDMR Dealing
2nd Sep 20214:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSPublication of bioMSAR Test Results
23rd Aug 20217:00 amRNSGreenfield Commercial Trial Agreement Extension
11th Aug 20217:00 amRNSUpdate on bioMSAR™ Testing
4th Aug 20217:00 amRNSUtah Project Update
30th Jul 20219:30 amRNSBlock Admissions
16th Jul 20214:40 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
16th Jul 20211:15 pmRNSDirectorate Change
28th Jun 20217:00 amRNSUpdate on bioMSAR™ and MSAR® projects
17th May 20214:40 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
4th May 20219:24 amRNSIssue of Equity
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:36 pmRNSPrice Monitoring Extension
16th Apr 20214:40 pmRNSSecond Price Monitoring Extn
16th Apr 20214:35 pmRNSPrice Monitoring Extension
1st Apr 202112:50 pmRNSUpdate re Greenfield Commercial Trial Agreement
29th Mar 20217:00 amRNSInterim Results
25th Mar 20214:40 pmRNSSecond Price Monitoring Extn
25th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSResults of Open Offer
12th Mar 20217:00 amRNSHolding(s) in Company
10th Mar 20217:00 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSResults of Placing and Open Offer Launch
1st Mar 20214:41 pmRNSProposed Placing and Open Offer
25th Feb 20214:41 pmRNSSecond Price Monitoring Extn
25th Feb 20214:35 pmRNSPrice Monitoring Extension
23rd Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSFinal Issue of Convertible Securities
4th Feb 20214:41 pmRNSSecond Price Monitoring Extn
4th Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.